David Juurlink

Where this writer stands

No opinion piece by this writer has been scored on a policy topic yet.

Only opinion columns and editorials are scored. Each piece is read twice by a language model, which records the author's own stance on a policy topic only where the piece argues one, with a quote that must appear in the piece. An author's position on a topic is the average of their pieces, weighted by the model's confidence. News reporting is listed but never scored.

Recent work

• Opinion | The case for decriminalizing drugsOpinion · Toronto Star · Apr 14, 2018
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Why Health Canada must reclassify tramadol as an opioidOpinion · The Globe and Mail · Nov 25, 2017
• Opioids: Whatever happened to ‘first, do no harm’?Opinion · The Globe and Mail · Aug 24, 2016
• Opioids: Whatever happened to ‘first, do no harm’?Opinion · The Globe and Mail · Aug 24, 2016
• Opioids: Whatever happened to ‘first, do no harm’?Opinion · The Globe and Mail · Aug 24, 2016
• Opioids: Whatever happened to ‘first, do no harm’?Opinion · The Globe and Mail · Aug 24, 2016
• Let the sun shine on doctors’ ties to pharmaOpinion · Toronto Star · May 9, 2016
• Let the sun shine on doctors' ties to pharma | Toronto StarOpinion · Toronto Star · May 8, 2016
• The importance of investigative reporting on drug safetyOpinion · Toronto Star · Feb 22, 2015
• Canada slow to respond to opioid addiction crisisOpinion · The Globe and Mail · Aug 13, 2014
• Ottawa CitizenOpinion · Ottawa Citizen · Nov 17, 2012